Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | 280,000 | reported | 02 Mar 2026 | tx 8+1,413,500−210,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 280,000 | 0.00 USD | deriv |
| 12 May 2025 | PURCHASE | Nautilus Biotechnology, Inc. | 1,500 | 0.73 USD | |
| 08 May 2025 | PURCHASE | Nautilus Biotechnology, Inc. | 12,000 | 0.73 USD | |
| 03 Mar 2025 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 280,000 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 280,000 | 0.00 USD | deriv |
| 27 Feb 2023 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 280,000 | 0.00 USD | deriv |
| 25 Feb 2022 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 280,000 | 0.00 USD | deriv |
| 21 Dec 2021 | GIFT | Nautilus Biotechnology, Inc. | 210,000 | 0.00 USD |